132 related articles for article (PubMed ID: 11522652)
21. A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells.
Mallory JC; Crudden G; Oliva A; Saunders C; Stromberg A; Craven RJ
Mol Pharmacol; 2005 Dec; 68(6):1747-56. PubMed ID: 16150928
[TBL] [Abstract][Full Text] [Related]
22. Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis.
Clifford JL; Walch E; Yang X; Xu X; Alberts DS; Clayman GL; El-Naggar AK; Lotan R; Lippman SM
Clin Cancer Res; 2002 Jul; 8(7):2067-72. PubMed ID: 12114405
[TBL] [Abstract][Full Text] [Related]
23. [Overexpression of synuclein-gamma confers resistance to antimicrotubule drugs against human hepatoma cells].
Cheng SX; Zhang S; Zhang H; Song DQ; Wang YP; Li YH; You XF; Wang YM; Jiang JD
Yao Xue Xue Bao; 2010 Jun; 45(6):724-9. PubMed ID: 20939180
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cells.
Manara MC; Serra M; Benini S; Picci P; Scotlandi K
Int J Oncol; 2004 Feb; 24(2):365-72. PubMed ID: 14719113
[TBL] [Abstract][Full Text] [Related]
25. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
[TBL] [Abstract][Full Text] [Related]
26. Description of paclitaxel resistance-associated genes in ovarian and breast cancer cell lines.
Duan Z; Lamendola DE; Duan Y; Yusuf RZ; Seiden MV
Cancer Chemother Pharmacol; 2005 Mar; 55(3):277-85. PubMed ID: 15565326
[TBL] [Abstract][Full Text] [Related]
27. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
28. Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT.
Liu Y; Chen L; Ko TC; Fields AP; Thompson EA
Oncogene; 2006 Jun; 25(25):3565-75. PubMed ID: 16462766
[TBL] [Abstract][Full Text] [Related]
29. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
[TBL] [Abstract][Full Text] [Related]
30. CpG-DNA-induced IFN-alpha production involves p38 MAPK-dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors.
Takauji R; Iho S; Takatsuka H; Yamamoto S; Takahashi T; Kitagawa H; Iwasaki H; Iida R; Yokochi T; Matsuki T
J Leukoc Biol; 2002 Nov; 72(5):1011-9. PubMed ID: 12429724
[TBL] [Abstract][Full Text] [Related]
31. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
32. [Chemosensitivity test for 170 human breast carcinoma samples].
He Z; Yuan J; Chen Z; Liu S; Shen Z; Fei H
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):531-4. PubMed ID: 10806759
[TBL] [Abstract][Full Text] [Related]
33. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer.
Alli E; Bash-Babula J; Yang JM; Hait WN
Cancer Res; 2002 Dec; 62(23):6864-9. PubMed ID: 12460900
[TBL] [Abstract][Full Text] [Related]
34. Characterization of human breast adenocarcinoma SK-BR-3 cells resistant to doxorubicin.
Osmak M; Kapitanović S; Vrhovec I; Beketić-Oresković L; Jernej B; Eljuga D; Skrk J
Neoplasma; 1997; 44(3):157-62. PubMed ID: 9372856
[TBL] [Abstract][Full Text] [Related]
35. Combining theoretical analysis and experimental data generation reveals IRF9 as a crucial factor for accelerating interferon α-induced early antiviral signalling.
Maiwald T; Schneider A; Busch H; Sahle S; Gretz N; Weiss TS; Kummer U; Klingmüller U
FEBS J; 2010 Nov; 277(22):4741-54. PubMed ID: 20964804
[TBL] [Abstract][Full Text] [Related]
36. Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells.
Alli E; Yang JM; Ford JM; Hait WN
Mol Pharmacol; 2007 May; 71(5):1233-40. PubMed ID: 17272681
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel induces release of cytochrome c from mitochondria isolated from human neuroblastoma cells'.
André N; Braguer D; Brasseur G; Gonçalves A; Lemesle-Meunier D; Guise S; Jordan MA; Briand C
Cancer Res; 2000 Oct; 60(19):5349-53. PubMed ID: 11034069
[TBL] [Abstract][Full Text] [Related]
38. The type I interferon-alpha mediates a more severe neurological disease in the absence of the canonical signaling molecule interferon regulatory factor 9.
Hofer MJ; Li W; Lim SL; Campbell IL
J Neurosci; 2010 Jan; 30(3):1149-57. PubMed ID: 20089923
[TBL] [Abstract][Full Text] [Related]
39. Six1 mediates resistance to paclitaxel in breast cancer cells.
Li Z; Tian T; Hu X; Zhang X; Nan F; Chang Y; Lv F; Zhang M
Biochem Biophys Res Commun; 2013 Nov; 441(3):538-43. PubMed ID: 24184484
[TBL] [Abstract][Full Text] [Related]
40. DNA damage increases sensitivity to vinca alkaloids and decreases sensitivity to taxanes through p53-dependent repression of microtubule-associated protein 4.
Zhang CC; Yang JM; Bash-Babula J; White E; Murphy M; Levine AJ; Hait WN
Cancer Res; 1999 Aug; 59(15):3663-70. PubMed ID: 10446979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
